These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2806384)
21. Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction. Selig WM; Bloomquist MA; Cohen ML; Fleisch JH Pulm Pharmacol; 1988; 1(2):93-9. PubMed ID: 2980293 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the effect of irindalone, a novel serotonin 5-HT2 antagonist and ketanserin on mechanical responses of rat thoracic aorta. Mikkelsen EO; Nyborg NC; Jensen KT; Boeck V Eur J Pharmacol; 1988 Apr; 149(1-2):145-8. PubMed ID: 3396624 [TBL] [Abstract][Full Text] [Related]
23. Serotonin enhances sympathetic vasoconstrictor responses in rat isolated perfused tail artery by activation of postjunctional serotonin-2 receptors. Medgett IC; Fearn HJ; Rand MJ Clin Exp Pharmacol Physiol; 1984; 11(4):343-6. PubMed ID: 6518663 [TBL] [Abstract][Full Text] [Related]
24. Endothelial thromboxane production plays a role in the contraction caused by 5-hydroxytryptamine in rat basilar arteries. Descombes JJ; Devys M; Laubie M; Verbeuren TJ Eur J Pharmacol; 1993 Oct; 243(2):193-9. PubMed ID: 8276069 [TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists. Conolan S; Quinn MJ; Taylor DA Br J Pharmacol; 1986 Sep; 89(1):129-35. PubMed ID: 3801767 [TBL] [Abstract][Full Text] [Related]
26. Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery. Conti A; Monopoli A; Forlani A; Ongini E; Antona C; Biglioli P Eur J Pharmacol; 1990 Feb; 176(2):207-12. PubMed ID: 2138088 [TBL] [Abstract][Full Text] [Related]
27. Effect of serotonin on cytosolic free calcium in adrenal glomerulosa and vascular smooth muscle cells. Capponi AM; Lew PD; Vallotton MB Eur J Pharmacol; 1987 Nov; 144(1):53-60. PubMed ID: 3325295 [TBL] [Abstract][Full Text] [Related]
28. Effects of oxyhemoglobin on vasoconstriction in response to 5-hydroxytryptamine in isolated, perfused canine basilar arteries. Orz YI; Tsuji T; Aoki T; Yen Y; Chiba S; Kobayashi S Neurosurgery; 1998 Nov; 43(5):1176-84. PubMed ID: 9802861 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor. Christie MI; Harper D; Smith GW Br J Pharmacol; 1992 Dec; 107(4):1008-12. PubMed ID: 1361397 [TBL] [Abstract][Full Text] [Related]
30. Vasoconstrictor mechanism of 5-hydroxytryptamine in isolated and perfused canine basilar arteries. Tsuji T; Chiba S Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):111-22. PubMed ID: 3592852 [TBL] [Abstract][Full Text] [Related]
31. Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep. Webber SE; Salonen RO; Widdicombe JG Br J Pharmacol; 1990 Jan; 99(1):21-6. PubMed ID: 2331572 [TBL] [Abstract][Full Text] [Related]
32. Evidence for a 5-HT1-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery. de la Lande IS Br J Pharmacol; 1992 Sep; 107(1):550-5. PubMed ID: 1422578 [TBL] [Abstract][Full Text] [Related]
33. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin. Van Nueten JM; Janssens WJ J Hypertens Suppl; 1986 Apr; 4(1):S55-9. PubMed ID: 2939213 [TBL] [Abstract][Full Text] [Related]
34. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Saxena PR; Lawang A Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009 [TBL] [Abstract][Full Text] [Related]
35. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Meller ST; Lewis SJ; Brody MJ; Gebhart GF Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336 [TBL] [Abstract][Full Text] [Related]
36. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery. Frenken M J Pharmacol Exp Ther; 1989 Jul; 250(1):379-87. PubMed ID: 2545865 [TBL] [Abstract][Full Text] [Related]
37. The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance. Higenbottam T; Marriott H; Cremona G; Laude E; Bee D Chest; 1999 Oct; 116(4):921-30. PubMed ID: 10531154 [TBL] [Abstract][Full Text] [Related]
38. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Cummings SA; Groszmann RJ; Kaumann AJ Br J Pharmacol; 1986 Nov; 89(3):501-13. PubMed ID: 3801785 [TBL] [Abstract][Full Text] [Related]
39. 5-HT2 receptors, roles and regulation. Leysen JE; Pauwels PJ Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309 [TBL] [Abstract][Full Text] [Related]
40. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Eddahibi S; Raffestin B; Pham I; Launay JM; Aegerter P; Sitbon M; Adnot S Am J Physiol; 1997 Mar; 272(3 Pt 2):H1173-81. PubMed ID: 9087590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]